Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 May;30(5):906.
doi: 10.1681/ASN.2019020124. Epub 2019 Mar 25.

Authors' Reply

Igor Denizarde Bacelar Marques  1 , Rosilene Motta Elias  2 , Rosa Maria Affonso Moysés  2 , Elias David-Neto  3   2
Affiliations
Comment

Authors' Reply

Igor Denizarde Bacelar Marques et al. J Am Soc Nephrol. 2019 May.
No abstract available

Keywords: kidney disease; renal osteodystrophy; zoledronic acid.

PubMed Disclaimer

Comment on

References

    1. Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, et al. .: A randomized trial of zoledronic acid to prevent bone loss in the first year after kidney transplantation. J Am Soc Nephrol 30: 355–365, 2019 - PMC - PubMed
    1. Segaud N, Legroux I, Hazzan M, Noel C, Cortet B: Changes in Bone Mineral Density after kidney transplantation: 2-year assessment of a French cohort. Osteoporos Int 29: 1165–1175, 2018 - PubMed
    1. Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Robinson A, et al. .: OPTN/SRTR 2016 annual data report: Kidney. Am J Transplant 18[Suppl 1]: 18–113, 2018 - PMC - PubMed
    1. Bezerra de Carvalho KS, Vasco RFV, Custodio MR, Jorgetti V, Moysés RMA, Elias RM: Chronic kidney disease is associated with low BMD at the hip but not at the spine [published online ahead of print January 28, 2019]. Osteoporos Int 10.1007/s00198-019-04864-4 - DOI - PubMed

Substances